date:Aug 25, 2014
een a dramatic reduction in the cost of generating results.
The approach, called IdentiSNP, offers a clear alternative to the established approach and opportunities to commercialise the product are now being actively pursued on a global basis.
To support the development IdentiGEN has recruited experienced additional staff including molecular biologists and product managers.
While this technology has transformed our internal cost base, and will support our continued growth and development in t